Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| UNITED THERAPEUTICS CorpUTHR · Entity 664 | Director | July 22, 2026 | July 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
UNITED THERAPEUTICS Corp
Report date July 22, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $527.07 · Expires 2033-07-22 | Direct | 2,380 |
Reported balance
After 2026-07-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-22 · Grant · Acquired 2,380 · Balance 2,380 F1: Annual non-employee director award. F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. |
| Common StockSEC Table I · non-derivative | Direct | 4,190 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 4,190 |
Filing footnotes · ownership attribution and instrument terms
F1: Annual non-employee director award.
F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2020 Filed Jan 4, 2021 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 7,500 | $0.00 Strike: $88.03 | $0.00 |
DisclosureSEC source: 0001127602-21-000199 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 7,500 shares Expires 2024-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 7,500 | $151.79 | $1,138,425.00 |
DisclosureSEC source: 0001127602-21-000199 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 7,500 | $88.03 | $660,225.00 |
DisclosureSEC source: 0001127602-21-000199 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 1,500 | $0.00 Strike: $88.03 | $0.00 |
DisclosureSEC source: 0001127602-20-032379 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 1,500 shares Expires 2024-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 1,500 | $149.36 | $224,040.00 |
DisclosureSEC source: 0001127602-20-032379 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,500 | $88.03 | $132,045.00 |
DisclosureSEC source: 0001127602-20-032379 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 28, 2020 Filed Oct 29, 2020 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 2,000 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001127602-20-027648 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 28, 2020 Filed Oct 29, 2020 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 2,000 | $132.03 | $264,060.00 |
DisclosureSEC source: 0001127602-20-027648 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 28, 2020 Filed Oct 29, 2020 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,000 | $63.90 | $127,800.00 |
DisclosureSEC source: 0001127602-20-027648 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 22, 2020 Filed Oct 23, 2020 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 2,500 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001127602-20-027460 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,500 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 22, 2020 Filed Oct 23, 2020 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 2,500 | $122.10 | $305,250.00 |
DisclosureSEC source: 0001127602-20-027460 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 22, 2020 Filed Oct 23, 2020 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,500 | $63.90 | $159,750.00 |
DisclosureSEC source: 0001127602-20-027460 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 20:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 1,500 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001127602-20-027206 · form4.xml · derivative · entry 6 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 1,500 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 20:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001127602-20-027206 · form4.xml · derivative · entry 5 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 750 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 20:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 1,500 | $115.00 | $172,500.00 |
DisclosureSEC source: 0001127602-20-027206 · form4.xml · nonDerivative · entry 4 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 20:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,500 | $63.90 | $95,850.00 |
DisclosureSEC source: 0001127602-20-027206 · form4.xml · nonDerivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 20:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $115.00 | $86,250.00 |
DisclosureSEC source: 0001127602-20-027206 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 20:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $63.90 | $47,925.00 |
DisclosureSEC source: 0001127602-20-027206 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 12:04 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001127602-20-021066 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,750 Underlying: Common Stock · 750 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 12:04 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $120.33 | $90,247.50 |
DisclosureSEC source: 0001127602-20-021066 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 12:04 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $63.90 | $47,925.00 |
DisclosureSEC source: 0001127602-20-021066 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 17:55 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 10,320 | $0.00 Strike: $119.76 | $0.00 |
DisclosureSEC source: 0001104659-20-078793 · a4.xml · derivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,320 Underlying: Common Stock · 10,320 shares Expires not disclosed F1 · shares: Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders. F2 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. F3 · derivative.expiration_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 22:18 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001127602-20-019046 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 750 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 22:18 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $122.42 | $91,815.00 |
DisclosureSEC source: 0001127602-20-019046 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 22:18 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $63.90 | $47,925.00 |
DisclosureSEC source: 0001127602-20-019046 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| May 15, 2020 Filed May 18, 2020 20:40 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 3,750 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001127602-20-016954 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,250 Underlying: Common Stock · 3,750 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| May 15, 2020 Filed May 18, 2020 20:40 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 3,750 | $116.36 | $436,350.00 |
DisclosureSEC source: 0001127602-20-016954 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| May 15, 2020 Filed May 18, 2020 20:40 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 3,750 | $63.90 | $239,625.00 |
DisclosureSEC source: 0001127602-20-016954 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| May 05, 2020 Filed May 5, 2020 20:42 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GiftCommon Stock | 75 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-015448 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · price: Bona fide gift of shares to a 501(c)(3) charitable organization. Read SEC document |
| May 05, 2020 Filed May 5, 2020 20:42 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GiftCommon Stock | 75 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-015448 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F1 · price: Bona fide gift of shares to a 501(c)(3) charitable organization. Read SEC document |
| June 26, 2019 Filed Jun 28, 2019 20:21 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 12,610 | $0.00 Strike: $76.36 | $0.00 |
DisclosureSEC source: 0001127602-19-023022 · form4.xml · derivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,610 Underlying: Common Stock · 12,610 shares Expires 2029-06-26 F1 · shares: Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders. F2 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| April 04, 2019 Filed Apr 5, 2019 20:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001127602-19-014914 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 750 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| April 04, 2019 Filed Apr 5, 2019 20:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $118.49 | $88,867.50 |
DisclosureSEC source: 0001127602-19-014914 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| April 04, 2019 Filed Apr 5, 2019 20:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $63.90 | $47,925.00 |
DisclosureSEC source: 0001127602-19-014914 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 12:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001127602-19-011615 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,750 Underlying: Common Stock · 750 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 12:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $117.03 | $87,772.50 |
DisclosureSEC source: 0001127602-19-011615 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 12:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $63.90 | $47,925.00 |
DisclosureSEC source: 0001127602-19-011615 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 21:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001127602-19-004783 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 750 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 21:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $115.30 | $86,475.00 |
DisclosureSEC source: 0001127602-19-004783 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 21:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $63.90 | $47,925.00 |
DisclosureSEC source: 0001127602-19-004783 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 18, 2019 Filed Jan 22, 2019 22:01 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001127602-19-002480 · form4.xml · derivative · entry 8 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 750 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 18, 2019 Filed Jan 22, 2019 22:01 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $115.75 | $86,812.50 |
DisclosureSEC source: 0001127602-19-002480 · form4.xml · nonDerivative · entry 5 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 18, 2019 Filed Jan 22, 2019 22:01 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $63.90 | $47,925.00 |
DisclosureSEC source: 0001127602-19-002480 · form4.xml · nonDerivative · entry 4 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 20:08 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001127602-18-031856 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 750 shares Expires 2021-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 20:08 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $115.04 | $86,280.00 |
DisclosureSEC source: 0001127602-18-031856 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,555 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 20:08 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $54.77 | $41,077.50 |
DisclosureSEC source: 0001127602-18-031856 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 12:21 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001127602-18-029688 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 750 shares Expires 2021-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 12:21 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $125.11 | $93,832.50 |
DisclosureSEC source: 0001127602-18-029688 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,555 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| October 04, 2018 Filed Oct 9, 2018 12:21 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $54.77 | $41,077.50 |
DisclosureSEC source: 0001127602-18-029688 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| September 10, 2018 Filed Sep 10, 2018 20:05 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 810 | $119.00 | $96,390.00 |
DisclosureSEC source: 0001127602-18-027232 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,555 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.